HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Einat Peles Selected Research

Benzodiazepines

7/2015Differences in methylphenidate abuse rates among methadone maintenance treatment patients in two clinics.
1/2014Trends in substance abuse and infectious disease over 20 years in a large methadone maintenance treatment (MMT) clinic in Israel.
6/2011No change of sleep after 6 and 12 months of methadone maintenance treatment.
3/201015-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
8/2009Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dose.
3/2008Tricyclic antidepressants abuse, with or without benzodiazepines abuse, in former heroin addicts currently in methadone maintenance treatment (MMT).
4/2007Depression in methadone maintenance treatment patients: rate and risk factors.
1/2007Characterization of former heroin addict patients with Hepatitis C virus antibodies in a methadone maintenance treatment (MMT) clinic in israel.
4/2006Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Einat Peles Research Topics

Disease

8Substance-Related Disorders (Drug Abuse)
01/2016 - 02/2005
7Hepatitis C
09/2014 - 01/2007
6Cocaine-Related Disorders (Cocaine Addiction)
01/2016 - 01/2006
6Pain (Aches)
10/2015 - 02/2005
6Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
12/2014 - 07/2009
5Opioid-Related Disorders (Opiate Addiction)
09/2014 - 02/2005
3Heroin Dependence (Heroin Abuse)
01/2016 - 07/2008
3Gambling (Pathological Gambling)
12/2014 - 07/2009
3Mental Disorders (Mental Disorder)
12/2014 - 04/2007
3Hepatitis B
09/2011 - 01/2007
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
07/2015 - 01/2012
2Communicable Diseases (Infectious Diseases)
07/2015 - 01/2014
2Wounds and Injuries (Trauma)
09/2014 - 01/2012
2Neoplasms (Cancer)
03/2010 - 09/2004
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2015
1Post-Traumatic Stress Disorders (PTSD)
09/2014
1Long QT Syndrome
11/2013
1Multiple Personality Disorder (Multiple Personalities)
12/2012
1Birth Weight (Birth Weights)
03/2012
1Infection
09/2011
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
07/2008
1Torsades de Pointes (Torsade de Pointes)
02/2007
1Sleep Disorders
04/2006
1Hydrocephalus (Hydrocephaly)
09/2004
1Glioma (Gliomas)
09/2004

Drug/Important Bio-Agent (IBA)

24Methadone (Dolophine)FDA LinkGeneric
10/2015 - 02/2005
232-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
07/2015 - 02/2005
9BenzodiazepinesIBA
07/2015 - 04/2006
8Heroin (Diamorphine)IBA
01/2016 - 02/2007
5Cocaine (Cocaine HCl)IBA
01/2016 - 04/2007
2AntigensIBA
09/2011 - 01/2007
2Tetrahydrocannabinol (THC)FDA LinkGeneric
01/2008 - 04/2007
2AmphetaminesIBA
01/2008 - 04/2007
1gamma-Aminobutyric Acid (GABA)IBA
01/2016
1Glutamic Acid (Glutamate)FDA Link
01/2016
15-methoxy-methylindoleacetic acid (DBI)IBA
01/2016
1Neurotensin Receptors (Neurotensin Receptor)IBA
11/2015
1Amphetamine (Amfetamine)FDA LinkGeneric
07/2015
1Methylphenidate (Ritalin)FDA LinkGeneric
07/2015
1N-sulfo-2-aminotricarballylate (SATC)IBA
09/2014
1HIV AntibodiesIBA
01/2014
1Potassium Channels (Potassium Channel)IBA
11/2013
1Pain-FreeIBA
01/2011
1mu Opioid Receptors (mu Opioid Receptor)IBA
07/2008
1Amitriptyline (Elavil)FDA LinkGeneric
03/2008
1benzoylecgonineIBA
04/2007
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
09/2004
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2004